Science & technology · Pipeline & development
Cardiomyocytes in Persistent Cancer Therapy-related Cardiac Dysfunction Show Contractile and Natriuretic Peptide Signaling Signatures
BACKGROUND. Anthracycline and trastuzumab therapy of HER2-positive breast cancer causes cancer therapy-related cardiac dysfunction (CTRCD) in a subset of treated patients. Some recover cardiac function, others do not. Whether persistence is a cardiomyocyte-intrinsic property is unknown. OBJECTIVES. We sought to determine whether induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) from
Original source
Read the source — biorxiv.org ↗We link to the original publisher. The summary above is a short guide; read the original for the full details.